NCT00262236View on ClinicalTrials.gov

Efficacy and Safety of Aliskiren and Atenolol in Adults (>18) With Mild to Moderate Hypertension

PHASE3CompletedINTERVENTIONAL

Enrollment

693

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions

Hypertension

Interventions

DRUG

Aliskiren

Trial Locations (2)

Unknown

Investigative Centers

Novartis, Basel

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY